We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Five years after treatment, results showed a freedom ...
MedPage Today on MSN
Compounded Imiquimod Shows Promise for Ocular Surface Cancers
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface malignancies in a small case series. Ocular surface malignancies are typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback